baber/WOPTO huggingface dataset:
Patent EP-3993996-A1 (EP)
Title: Soundproofing coating comprising a cellular structure
Inventor: CARIOU CHARLES
IPC: B32B3/18
Filed: 2020-06-16
Abstract: The invention relates to a soundproofing coating with a cellular structure consisting of several structures (11) connected in a transverse direction (D2), each formed by connecting a first longitudinal strip (4) with a second longitudinal strip (5). Each structure (11) has, successively in the longitudinal direction (D1): - a first cavity (6), the cross-section of which narrows gradually in the thickness of the coating until it closes, - a first connection of two walls (71, 72), respectively of the first strip (4) and the second strip (5), in contact with each other over part of the thickness of the coating, which provides a passage (10) between the first cavity (6) and a second cavity (8) that thus form a Helmholtz resonator, - the second cavity (8), the cross-section of which gradually increases in the thickness of the coating and which is closed by a closing sheet, - a second connection of two walls (91, 92). A broadband soundproofing coating that can, in particular, process low frequencies is thus obtained by joining strips that can be obtained by conventional industrial means.
Patent EP-3980002-A1 (EP)
Inventor: FEIGE JEROME
IPC: A23L33/185
Filed: 2020-06-04
Abstract: A method of potentiating musculoskeletal effect of one or more anabolic amino acids in an individual in need thereof can include administering to the individual in need thereof a composition containing the one or more anabolic amino acids, the composition also containing one or more autophagy-inducing amino acids in a total amount effective for the composition to be at least neutral regarding autophagy. In another aspect, a method of overcoming one or more negative effects of one or more anabolic amino acids by preventing degenerative processes related to loss of autophagy can include administering to an individual in need thereof a composition containing the one or more anabolic amino acids, the composition further containing the one or more autophagy-inducing amino acids in a total amount effective for the composition to be at least neutral regarding autophagy.
Patent EP-3975993-A1 (EP)
Title: Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
Inventor: DONOVAN MARTIN
IPC: A61K9/08
Filed: 2020-05-29
Abstract: The present invention concerns the use of aprotic polar solvents, water, and an ionization stabilizing agent to prepare device compatible stable therapeutic formulations by dissolving a therapeutic agent (active ingredient) in an aprotic polar solvent system that can then be used with various devices (e.g., pumps, infusion sets) for administration of the formulation. In certain embodiments, the invention is directed to formulations comprising one or more therapeutic agents, as well as methods of making such formulations, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system, such as a DMSO/water admixture, comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.
Patent EP-3990414-A1 (EP)
Title: Method for producing a carbonate bonded, compacted article
Inventor: VAN MECHELEN DIRK
IPC: C04B28/08
Filed: 2020-06-26
Abstract: The method for producing a carbonate bonded, compacted article, which method comprises the steps of providing a particulate, carbonatable material; compacting the particulate material to form a compact; and carbonating said compact. The carbonation of the compact is started and subsequently continued for at least 1 hour with a low partial carbon dioxide pressure in the carbonation gas which is lower than 0.5 bars, after which carbonation of the compact is continued for at least 8 hours with a high partial carbon dioxide pressure in the carbonation gas which is higher than 0.5 bars. By carbonating in two phases with a low and a high partial carbon dioxide pressure, a higher compressive strength of the carbonated compacts can be achieved within a predetermined carbonation time, in particular within a carbonation time of about 24 hours so that every day new compacts can be carbonated.
Patent EP-3966327-A1 (EP)
Inventor: POLICE SESHIDHAR REDDY
IPC: A61K31/7088
Filed: 2020-05-08
Abstract: The present disclosure provides materials and methods for treating a patient with Duchenne Muscular Dystrophy (DMD), e.g., through ex vivo and in vivo methods of genome editing. The present disclosure also relates to methods and compositions for use of self-inactivating/self-targeting CRISPR/Cas or CRISPR/Cpfl systems to genetically modify cells, e.g., to modulate the expression, function, and/or activity of the dystrophin gene.
Patent EP-4004645-A1 (EP)
Title: Device and method for monitoring the drying/curing process of coatings
Inventor: LIBUTZKI HARRY
IPC: B05D5/00
Filed: 2020-07-29
Abstract: The present invention relates to a device for monitoring the drying and/or curing process of a coating composition applied at least partially onto at least one surface of a substrate, said device comprising a movable skid (1), which skid (1) in turn comprises at least one substrate holding unit (2), at least one lamp (3) used as light source, at least one pattern holder (4) including a pattern, as well as at least one camera (5), wherein substrate holding unit (2), lamp (3) and pattern holder (4) are positioned on skid (1) relative to each other such that light of lamp (3) can illuminate the pattern of pattern holder (4), and after said illumination be projected onto the surface of the substrate, which is held by the substrate holding unit (2), and wherein camera (5) is positioned on the skid (1) relative to substrate holding unit (2) holding the substrate, such that camera (5) is capable of recording images of the light reflected off the surface of said substrate, a use of said device for monitoring the drying and/or curing process of a coating composition applied onto the surface of a substrate, a corresponding method making use of said device as well as a kit-of- parts comprising the device and an oven, as well as to a method of evaluating appearance properties and/or surface properties of a coating obtained by applying the coating composition during drying and/or curing.
Patent EP-4004720-A1 (EP)
Inventor: GRIFFIN KYLE
IPC: G06F9/50
Filed: 2020-06-03
Abstract: The embodiments of the present disclosure are generally directed to systems and methods for provisioning computing resources using computer vision. An image comprising a plurality of visual elements can be received. The visual elements within the image can be recognized as objects that represent network elements, where the recognized objects represent network elements of a network element type and the network element types comprise one or more of a database, a load balancer, a sub-network, or a virtual machine instance, and an arrangement of the recognized objects that represents a network architecture is recognized. Computing resources can be caused to be provisioned corresponding to the recognized objects by provisioning network elements that comprise one or more of the network element types, wherein the provisioning comprises generating a network architecture for the provisioned network elements based on the recognized arrangement.
Patent EP-3987206-A1 (EP)
Inventor: BIANCALANI MASSIMO
IPC: F16K31/122
Filed: 2020-06-19
Abstract: A machine for treating a fabric (T) with air comprises a duct (10) for pneumatic transfer of the fabric, which has a diverter valve (16) located substantially halfway of the duct and equipped with an angularly adjustable deflector (17) adapted to completely or partially block air access in two channels (16a, 16b) oriented to direct the air flow (F) introduced into the duct in one direction or the other. A control unit (UC) instantaneously detects the angular position of the deflector (17) by means of an electronic sensor (26) and actuates a pneumatic cylinder (20) for controlling the deflector (17) via two pneumatic solenoid valves (22, 24) arranged in parallel and having different flow rates.
Patent EP-3926060-A1 (EP)
Inventor: MURAKAWA TESSHU
IPC: C21D8/12
Filed: 2020-02-14
Abstract: The present disclosure has as its object the provision of non-oriented electrical steel sheet excellent in magnetic properties which is free from any drop in magnetic flux density even after stress relief annealing and a method for manufacturing the same. 
     Non-oriented electrical steel sheet having a chemical composition containing C: 0.0030 mass% or less, Si: 2.0 mass% or more and 4.0 mass% or less, Al: 0.010 mass% or more and 3.0 mass% or less, Mn: 0.10 mass% or more and 2.4% mass or less, P: 0.0050 mass% or more and 0.20 mass% or less, S: 0.0030 mass% or less, and one or more elements selected from the group comprising Mg, Ca, Sr, Ba, Ce, La, Nd, Pr, Zn, and Cd: total 0.00050 mass% or more and having a balance of Fe and unavoidable impurities, where, when designating a mass% of Si as [Si], a mass% of Al as [Al], and a mass% of Mn as [Mn], a parameter Q shown by the following formula (1) is 2.0 or more, a random intensity ratio of the {100} orientation is 2.4 or more, and an average grain size is 30  µ m or less:      Q   =     Si     +   2     A   1     −     Mn
Patent EP-3929205-A1 (EP)
Inventor: TAKAHASHI DAISUKE
IPC: C12N15/10
Filed: 2020-02-18
Abstract: The present invention provides a method for efficiently producing an oligonucleotide comprising a complementary portion, such as an siRNA and a heteroduplex oligonucleotide. More specifically, provided is a method for producing a modified oligonucleotide comprising a complementary portion having 11 to 27 nucleotide length, in which the method includes formation of the modified oligonucleotide by treating four or more oligonucleotide raw material fragments in total in the presence of an oligonucleotide ligase; the four or more oligonucleotide raw material fragments in total correspond to oligonucleotide raw material fragments that are obtained by dividing the modified oligonucleotide at a fragment linking site that satisfies following conditions (i) to (v): (i) one or more fragment linking sites are present in the complementary portion in each strand side, and two or more fragment linking sites in total are present in the modified oligonucleotide; (ii) when the modified oligonucleotide is divided at the fragment linking site, a sticky end is formed in the complementary portion, in which the sticky end has 1 to 10 nucleotide length; (iii) at least one oligonucleotide raw material fragment has a modified nucleotide; (iv) four oligonucleotide raw material fragments out of the four or more oligonucleotide raw material fragments in total include the complementary portion having 5 to 25 nucleotide length; and (v) total nucleotide length of the oligonucleotide raw material fragments corresponding to the complementary portions in each strand side is 11 to 27.
Patent EP-4007649-A1 (EP)
Title: Active phospholipid membrane and related production process
Inventor: SINOPOLI PAOLO
IPC: B01D71/74
Filed: 2020-07-30
Abstract: Active phospholipidic membrane (200) comprising: - a double phospholipidic layer; - at least a support (201) for supporting the double phospholipidic layer thus improving the resistance of the active phospholipidic membrane (200); - a plurality of monoclonal antibodies (202) bonded to the support (201); - a plurality of predetermined molecules (203) bound to the monoclonal antibodies (202) at a transmembrane level. Said supports (201) comprises a first substrate comprising the monoclonal antibodies (202) and a second substrate comprising the double phospholipidic layer.
Patent EP-4013864-A1 (EP)
Inventor: BOWEN TYSON D
IPC: C12Q1/6816
Filed: 2020-08-11
Abstract: Compositions and methods for binding to a target sequence of interest are provided. The compositions find use in cleaving or modifying a target sequence of interest, visualization of a target sequence of interest, and modifying the expression of a sequence of interest. Compositions comprise RNA-guided nuclease polypeptides, CRISPR RNAs, trans-activating CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding the same. Vectors and host cells comprising the nucleic acid molecules are also provided. Further provided are CRISPR systems for binding a target sequence of interest, wherein the CRISPR system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs. Methods and kits for detecting a target DNA sequence are also provided.
Patent EP-3916207-A1 (EP)
Inventor: NAGAFUCHI NAOYUKI
IPC: F02C3/34
Filed: 2020-01-31
Abstract: A gas turbine plant includes an exhaust line (L1), a carbon dioxide recovery device (3) configured to recover carbon dioxide contained in an exhaust gas, a circulation line (L2) connected to a gas turbine (1), a first valve device (V1), a bypass line (L3) bypassing the carbon dioxide recovery device (3), a second valve device (V2) provided on the bypass line (L3), a third valve device (V3) provided at a position between the bypass line (L3) and the carbon dioxide recovery device (3), a densitometer (D) configured to detect a carbon dioxide concentration in the exhaust gas, and a control device (90) configured to adjust opening degrees of the first valve device (V1), the second valve device (V2), and the third valve device (V3) based on an operation state of the gas turbine (1) and the carbon dioxide concentration.
Patent EP-3930852-A1 (EP)
Inventor: ZHOU HEYUE
IPC: A61P35/02
Filed: 2020-02-25
Abstract: The present disclosure provides BCMA binding proteins, particularly anti-BCMA antibodies, or antigen-binding portions thereof, that specifically bind BCMA and uses thereof. In one embodiment, the anti-BCMA antibody comprises an antigen binding portion that binds a human BCMA epitope and blocks binding (e.g, inhibits binding) of human APRIL and/or human BAFF to the human BCMA epitope. Various aspects of the anti-BCMA antibodies relate to antibody fragments, single-chain antibodies, pharmaceutical compositions, nucleic acids, recombinant expression vectors, host cells, and methods for preparing and using such anti-BCMA antibodies. Methods for using the anti-BCMA antibodies include in vitro and in vivo methods for binding BCMA, detecting BCMA and treating diseases associated with BCMA over-expression.
Patent EP-4010686-A1 (EP)
Inventor: SFEZ BRUNO
IPC: G01N21/51
Filed: 2020-08-06
Abstract: L'invention concerne un appareil permettant de générer une carte bidimensionnelle représentative d'un milieu (11) trouble ou clair, qui comprend un système (12) destiné à générer une lumière incohérente à l'intérieur d'un milieu (11), un système de collecte de lumière (13) qui est mobile ou fixe par rapport au milieu (11) analysé et qui est agencé pour collecter la lumière sortant du milieu (11) et un analyseur de spectre (14) conçu pour déterminer des données de spectre de la lumière sortant du milieu (11) trouble et pour transmettre les données de spectre à une unité de calcul (15). L'unité de calcul (15) est conçue pour générer une carte bidimensionnelle, une dimension de la carte étant une longueur d'onde et une seconde dimension étant une position du système de collecte de lumière (13). L'invention concerne également un procédé de classification de milieux à l'aide de la carte bidimensionnelle générée avec l'appareil. Le procédé comprend des étapes d'alimentation et d'entraînement de réseaux neuronaux et d'utilisation des réseaux neuronaux entraînés pour classifier des milieux inconnus.
Patent EP-3939219-A1 (EP)
Inventor: MOSHE YUVAL
IPC: H04L12/00
Filed: 2020-03-05
Abstract: A system and a method are provided for use in an MPLS network, wherein the system comprises at least one routing element configured to share one or more circuits among multiple Intermediate System to Intermediate System (IS-IS) routing protocol instances, wherein each of the multi instances is associated with a unique database, and wherein the at least one routing element comprises a managing entity configured to: manage a plurality of traffic engineering software agents each associated with a respective database, and allocate available resources to respective instances; update at least one of the plurality of databases; and for traffic that is about to be conveyed via a specific instance, determine a neighboring instance through which said traffic will be conveyed, based on information comprised in the database associated with the specific instance through which said traffic will be conveyed.
Patent EP-3918800-A1 (EP)
Inventor: ZHANG KAI
IPC: H04N19/82
Filed: 2020-03-09
Abstract: A video processing method is provided to comprise: performing a conversion between a coded representation of a video comprising one or more video regions and the video, wherein the coded representation includes reshaping model information applicable for in-loop reshaping (ILR) of some of the one or more video regions, wherein the reshaping model information provides information for a reconstruction of a video unit of a video region based on a representation in a first domain and a second domain and/or scaling chroma residue of a chroma video unit, wherein the reshaping model information comprises a parameter set that includes a first syntax element that derives a number of bits used to represent a second syntax element specifying an absolute delta codeword value from a corresponding bin, and wherein the first syntax element has a value smaller than a threshold.
Patent EP-4031867-A1 (EP)
Inventor: JULIEN GUILLAUME
IPC: G01N33/68
Filed: 2020-09-16
Abstract: The invention relates to a device (12, 112, 212) for taking a biological liquid sample intended to be able to be inserted into a portable reader (14) able to analyse the biological liquid, the device (12, 112, 212) comprising a strip (30, 130, 230) comprising, on its upper face, a plurality of colour-changing reactive elements (32, 132, 232) arranged one after the other; an absorbent assembly (28, 128, 228) comprising a deposition portion (37, 137, 237) on which to deposit the biological liquid; a band (38, 138, 238) for the diffusion of the biological liquid arranged over the top of the plurality of reactive elements (32, 132, 232); a housing (16, 116, 216) comprising a housing bottom (24, 124, 224), the strip (30, 130, 230) being arranged in the bottom of the housing (24, 124, 224), the lower face of the strip (30, 130, 230) being arranged facing the housing bottom (24, 124, 224), each reactive element (32, 132, 232) being arranged by transparency through the strip (30, 130, 230) facing an opening (52, 152, 252) in the housing bottom (24, 124, 224); a cover (26, 126, 226) arranged over the top of the diffusion band (38, 138, 238) and comprising at least one protruding pattern (60, 172, 288) forming a pressing surface configured to press the diffusion band (38, 138, 238) into contact with the plurality of reactive elements (32, 132, 232); an access opening (56, 156, 256) configured to provide access to the deposition portion (37, 137, 237).
Patent EP-3942382-A1 (EP)
Inventor: JIANG YU
IPC: G01C21/14
Filed: 2020-03-19
Abstract: Localization systems, including road surface-based localization systems, are disclosed that may work in conjunction with less precise systems, such as GPS, to accurately locate a vehicle on a road segment. Methods and apparatus are disclosed for the identification and selection of landmarks, including road surface-based landmarks.
Patent EP-3952184-A1 (EP)
Inventor: PENG SHUYAN
IPC: H04L5/00
Filed: 2020-03-31
Abstract: This disclosure provides a method for determining a channel resource, a channel detection method, and a terminal. The method includes: obtaining a candidate resource of a physical sidelink control channel PSCCH, where the candidate resource is in a subchannel of the PSCCH, or the candidate resource is in a subchannel of a PSSCH resource selected by the terminal, or the candidate resource is in a frequency domain range of a PSSCH resource selected by the terminal, or the candidate resource is in a resource set; and determining a transmission resource of the to-be-transmitted PSCCH based on the candidate resource.
Patent EP-3927591-A1 (EP)
Inventor: BOWEN CHRISTOPHER
IPC: B60W40/10
Filed: 2020-04-01
Abstract: The technology relates to determining whether a vehicle operating in an autonomous driving mode is experiencing an anomalous condition, for instance due to a loss of tire pressure, a mechanical failure, or a shift or loss of cargo. The actual current pose of the vehicle is compared to an expected pose of the vehicle, where the expected pose is based on a model of the vehicle (1012). If a pose discrepancy is identified (1014), the anomalous condition is determined from information associated with the pose discrepancy (1016). The vehicle is then able to take corrective action based on the nature of the anomalous condition (1018). The corrective action may include making a real-time driving change, modifying a planned route, alerting a remote operations center, or communicating with one or more other vehicles.
Patent EP-3946300-A1 (EP)
Title: Combinations of transcription inhibitors and immune checkpoint inhibitors for treatment of disease
Inventor: PRIEBE WALDEMAR
IPC: A61K39/395
Filed: 2020-04-02
Abstract: Provided herein are methods of treating patients with a combination of a transcription inhibitor (e.g., a STAT3 inhibitor) and an immune checkpoint blockade therapy (e.g., anti- PD-1 therapy, anti-PD-L1 therapy, anti-CTLA-4 therapy). The patient may have a proliferative disease, such as cancer or psoriasis. The patient may have a pathogenic infection.
Patent EP-4048943-A1 (EP)
Inventor: WIRTH NICHOLAS
IPC: F21V7/00
Filed: 2020-09-30
Abstract: A flow control device for controlling an air curtain formed across a display area of a refrigerated display case, the flow control device comprising: a stabilising beam comprising an elongate outer cover (52) and a carrier (54); wherein the outer cover (52) forms a continuous boundary which defines a cavity (56) extending along the length of the outer cover (52); wherein the carrier (54) is slidably received within the cavity (56) along the length of the outer cover (52); wherein the carrier (54) is provided with a light source (68) and wherein at least a portion of the outer cover (52) is transparent or translucent such that light emitted by the light source is emitted from the outer cover (52) to provide illumination.
Patent EP-3939428-A1 (EP)
Inventor: WANG JIANJUN
IPC: A01N1/00
Filed: 2020-03-02
Abstract: Disclosed is a serum-free cryopreservation solution, containing: a biomimetic ice control material, a polyol, a water-soluble sugar, and a buffer solution margin; the bionic ice control material can be polyvinyl alcohol or an amino acid compound. The cryopreservation liquid of the present invention uses the bionic ice control material as the main component, does not contain serum, has low toxicity, and can achieve a cell survival rate that is the same as, or higher than, existing cryopreservation solutions. The cryopreservation solution of the present invention has simple composition, the source of raw materials is convenient, costs are low, and it can be widely used in cryopreservation of various cells and tissues.
Patent EP-4037755-A1 (EP)
Inventor: ODAKA RYUGO
IPC: A61N1/36
Filed: 2020-09-30
Abstract: A body electrode unit includes a body electrode and a release sheet to which the body electrode is attached. The body electrode includes a first electrode configured to stimulate a muscle of a body, a second electrode, and a third electrode. The second electrode and the third electrode are configured to detect a physiological signal from the muscle that is stimulated by the first electrode. The body electrode also includes a first connection portion arranged between the first electrode and the second electrode, and a second connection portion arranged between the third electrode and one of the first electrode and the second electrode. The first connection portion has at least one first direction changing part configured to change a direction in which the first connection portion extends, such that at least one of a distance and an angle between the first electrode and the second electrode is adjustable.